 |
Sanofi launches $18.5bn bid for GenzymeFrench drugmaker Sanofi-Aventis launched a hostile bid for Genzyme at $69 per share on Monday, taking its $18.5 billion offer direct to shareholders after Genzyme management refused to negotiate. The move comes a month after Genzyme More… |
 |
Sanofi launches anti-ageing drug in UAESanofi-aventis pharmaceuticals, has announced the launch of its new anti-ageing drug, Sculptra in UAE following its recent approval from the UAE Ministry of Health. Sculptra is an injectable treatment that consists of poly-L-lactic acid st More… |
 |
Experts plan diabetes awareness driveSome of the most experienced diabetes specialists from across the Middle East recently met in Abu Dhabi at a two-day brainstorming and knowledge sharing session aimed at raising awareness of type 2 diabetes in the region. Known as DEVOTED, More… |
 |
40 Gulf doctors get Sanofi-aventis grantsSanofi-aventis pharmaceuticals has announced complimentary educational grants to 40 gulf specialists to take part in a Cardiff University Post Graduate Diabetes Diploma. The postgraduate diploma in diabetes is a two year part-time, distanc More… |
 |
Sanofi-aventis' new insulin injection more efficientSanofi-aventis has announced the results of new analysis that found a significantly lower risk of nocturnal hypoglycemia with Lantus (insulin glargine [rDNA] injection) as compared to NPH insulin. A separate post-hoc sub-analysis found a g More… |
 |
Sanofi-aventis awards grants to 5 GCC doctorsSanofi-aventis has awarded grants to five doctors from across the GCC region, to implement new research, screening and care initiatives to prevent and treat diabetes in the region. The grants are part of Sanofi’s ‘Devoted’ initiative, laun More… |
 |
Sanofi-aventis drug wins EMA clearanceSanofi-aventis, a leading global pharmaceutical company, has confirmed that changes to the prescribing advice of its new insulin injection are not necessary following a review of the drug by a committee of the European Medicines Agency (EMA). More… |
 |
Sanofi starts mass production of H1N1 vaccineFrench drug maker Sanofi-Aventis has begun large-scale production of a vaccine for the H1N1 swine flu at its facilities in the United States and France, the company said. Production of the vaccine for the new flu virus, which has caused a More… |
 |
Varsity launches diabetes courseThe UAE – University has launched a multidisciplinary diabetes education course which will establish the first professionally certified and recognised diabetes educators in the UAE. The course is established in the framework of a non-for-p More… |
 |
Saudi diabetes website wins Sanofi awardSolaiman Bader Al-Motair, a Saudi researcher based at the King Abdulaziz City for National Guard in Riyadh, won the Sanofi-aventis award for best website, for raising awareness of diabetes. Al-Motair's diabetes online portal can be fou More… |
